Alto Neuroscience logo

Alto Neuroscience Share Price (NYSE: ANRO)

$3.69

-0.12

(-3.15%)

Last updated on

Check the interactive Alto Neuroscience Stock chart to analyse performance

Alto Neuroscience stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.58
    Today's High:$3.82

    Day's Volatility :6.28%

  • 52 Weeks Low:$1.60
    52 Weeks High:$15.04

    52 Weeks Volatility :89.36%

Alto Neuroscience Stock Returns

PeriodAlto Neuroscience, Inc.Index (Russel 2000)
3 Months
42.69%
0.0%
6 Months
18.15%
0.0%
1 Year
-71.89%
0.0%
3 Years
-82.08%
-4.7%

Alto Neuroscience, Inc. Key Stats

Check Alto Neuroscience key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.81
Open
$3.81
Today's High
$3.82
Today's Low
$3.58
Market Capitalization
$103.2M
Today's Volume
$90.0K
52 Week High
$15.04
52 Week Low
$1.6
Revenue TTM
$0.0
EBITDA
$-69.6M
Earnings Per Share (EPS)
$-2.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.79%

Stock Returns calculator for Alto Neuroscience Stock including INR - Dollar returns

The Alto Neuroscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Alto Neuroscience investment value today

Current value as on today

₹33,239

Returns

₹66,761

(-66.76%)

Returns from Alto Neuroscience Stock

₹72,045 (-72.05%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Alto Neuroscience Stock

-56%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Alto Neuroscience Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Alto Neuroscience Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Alto Neuroscience(by analysts ranked 0 to 5 stars)

Alto Neuroscience Share Price Target

What analysts predicted

Upside of 180.04%

Target:

$10.33

Current:

$3.69

Alto Neuroscience share price target is $10.33, a slight Upside of 180.04% compared to current price of $3.69 as per analysts' prediction.

Alto Neuroscience Stock Insights

  • Price Movement

    In the last 1 year, ANRO stock has moved down by -71.0%
  • ANRO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 140.9%

Alto Neuroscience Technicals Summary

Sell

Neutral

Buy

Alto Neuroscience is currently in a neutral trading position according to technical analysis indicators.

Alto Neuroscience, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Alto Neuroscience, Inc. logo
21.64%
18.15%
-71.89%
-82.08%
-82.08%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Alto Neuroscience, Inc.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Organization
Alto Neuroscience
Employees
76
CEO
Dr. Amit Etkin M.D., Ph.D.
Industry
Miscellaneous

Key Management of Alto Neuroscience, Inc.

NameTitle
Dr. Amit Etkin M.D., Ph.D.
Founder, Chairman of the Board, CEO & President
Mr. Nicholas C. Smith
CFO & Chief Business Officer
Mr. Michael C. Hanley M.B.A.
Chief Operating Officer
Mr. Dan Segal B.Sc. (Hons), BCom, CA, MSc
Co-Founder & Strategic Advisor
Ms. Erin R. McQuade J.D.
General Counsel, Chief Administrative Officer & Corporate Secretary
Mr. Adam Savitz M.D., Ph.D.
Chief Medical Officer
Ms. Jessica Powell
Chief Development Officer

Important FAQs about investing in ANRO Stock from India :

What is Alto Neuroscience share price today?

Alto Neuroscience share price today is $3.69 as on at the close of the market. Alto Neuroscience share today touched a day high of $3.82 and a low of $3.58.

What is the 52 week high and 52 week low for Alto Neuroscience share?

Alto Neuroscience share touched a 52 week high of $15.04 and a 52 week low of $1.60. Alto Neuroscience stock price today i.e. is closed at $3.69, lower by 75.47% versus the 52 week high.

How to invest in Alto Neuroscience Stock (ANRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alto Neuroscience on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alto Neuroscience Shares that will get you 0.4065 shares as per Alto Neuroscience share price of $3.69 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Alto Neuroscience Stock (ANRO) from India?

Indian investors can start investing in Alto Neuroscience (ANRO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Alto Neuroscience stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Alto Neuroscience share’s latest price of $3.69 as on August 30, 2025 at 1:29 am IST, you will get 2.7100 shares of Alto Neuroscience. Learn more about fractional shares .

What are the returns that Alto Neuroscience has given to Indian investors in the last 5 years?

Alto Neuroscience stock has given -82.08% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?